Image-guided therapy
Prostate artery embolization
Enhancing confident planning and treatment in prostate artery embolization
Philips offers a minimally invasive approach to treating benign prostate hyperplasia, addressing the demand for less invasive techniques without the significant complications associated with current standard procedures such as prostatectomy. The Azurion Image Guided Therapy System supports you in confident planning and treatment decisions in prostate artery embolization (PAE) interventions with minimal X-ray dose and a clear visualization of the vasculature.
Confidence and efficiency in prostate artery embolization
Philips Azurion Image Guided Therapy System offers workflow innovations designed to help vascular teams work efficiently and consistently. It aids teams in addressing clinical challenges in prostate artery embolization while they maintain a single-minded focus on the patient and managing radiation dose during interventions. The highly intuitive usability of Azurion-supports you in quickly and confidently performing prostate artery embolization. With this future-proof platform you can deliver outstanding care and grow your service line over time.
Confident planning and treatment decisions with minimal X-ray dose
- With Azurion we offer you a clutter-free and comfortable lab environment, streamlined workflow through lab integration and industry-leading image quality at a fraction of the dose
- Empowers you to easily adopt 3D imaging in the lab with SmartCT
- Provides industry leading image quality at a fraction of the dose with ClarityIQ technology
- Provides outstanding detail with 2D DSA with ClarityIQ technology
Insightful planning and guidance for prostate artery embolization
- Azurion offers excellent visibility at ultra-low X-ray dose levels for a comprehensive range of clinical procedures with ClarityIQ technology on a 20” detector
- FlexVision displays all necessary and available information (e.g., live, reference, planning, roadmap overlay, patient monitoring or dose info)
- The touchscreen module Pro offers tableside control of images and applications with tablet ease to save time and the need to walk in and out of the sterile area
- SmartCT provides total tableside control and acquisition guidance, simplifying 3D acquisition
Featured solutions for prostate artery embolization
Azurion 7 M20 monoplane ceiling-mounted with FlexArm
This ceiling-mounted, compact system provides unlimited imaging flexibility for prostate artery embolization procedures, exceptional positioning freedom and a highly cost-effective environment. Philips Azurion 7 M20 with FlexArm helps advance interventional suite performance and care delivery.
SmartCT 3D visualization and measurement tool
SmartCT offers total tableside control and acquisition guidance. It simplifies 3D acquisition so any clinical user1 can easily perform 3D imaging. Segmentation tasks are semi-automated and made available on the touchscreen to speed up 3D image analysis and elevate treatment confidence.
ClarityIQ technology
ClarityIQ allows for low-dose fluoroscopy, offering tuned, high-definition low-dose images with superb vascular detail to monitor the embolization.2 Advanced spatial filtering highlights structures and reduces the impact of background noise in an image.
Cone beam CT is a must, and this is recognized by every user, whether beginners or late adopters or people who are very experienced, because of the help in being able to go faster and safer to complete the procedure.
Prof. Marc Sapoval
Head of Interventional Radiology
Hôpital Européen Georges Pompidou AP-HP
Related procedures
Discover Philips solutions for aortic disease interventions to support each step of a procedure, improving efficiency and helping redefine outcomes.
Philips’ portfolio includes advanced imaging and specialized treatment solutions for even the most difficult deep venous procedures.
Footnotes
- The user level of expertise required is described in the Instructions for Use as the Intended Operator Profile.
- In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. All study references are mentioned here: www.philips.com/Clinicallyproven
Disclaimer
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.